Services
Cancer treatment today is individualised: the right option depends on the cancer type, its stage and molecular profile, and the patient’s overall health and priorities. Every treatment plan is based on current evidence-based guidelines and discussed openly with the patient and family — what it involves, what it aims to achieve, and what side effects to expect — before it begins.
Chemotherapy
Planning and administration of chemotherapy for solid and blood cancers — as curative treatment, before or after surgery, or to control advanced disease. Regimens follow current evidence-based guidelines, with supportive medicines and close monitoring to manage side effects through every cycle.
Immunotherapy
Treatment with immune checkpoint inhibitors and other immune-based medicines that help the body’s own immune system act against cancer. Patient selection is guided by biomarker testing, and treatment includes structured monitoring for immune-related side effects.
Targeted Therapy
Oral and intravenous medicines directed at specific molecular alterations in the tumour — such as EGFR, ALK, HER2, and BRCA-related changes. Treatment is matched to the results of molecular testing of each patient’s cancer.
Precision Oncology & Genomic Testing
Guidance on when genomic tests (such as next-generation sequencing) are useful, help interpreting the reports, and matching the findings to approved targeted treatments or clinical trial options where appropriate.
Cancer Screening & Prevention Counselling
Age- and risk-appropriate screening advice — mammography, cervical (Pap/HPV) testing, colonoscopy, and others — along with HPV vaccination guidance, tobacco cessation support, and assessment of hereditary cancer risk with referral for genetic counselling where indicated.
Second Opinions
A structured review of an existing diagnosis, staging, and treatment plan based on your complete records — biopsy slides, scans, and prior treatment details. Seeking a second opinion before major treatment is a normal and reasonable step.